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Abstract: 
Rapid multimodal imaging is essential in the workup and management of acute 
ischemic stroke.  Early parenchymal findings on non-contrast CT or standard MRI are 
used to triage patients for intravenous thrombolysis and to provide insight on prognosis.  
In the wake of recent endovascular stroke trials, advanced techniques including 
perfusion imaging and noninvasive vascular imaging are becoming important tools to 
guide potential endovascular treatment or expand therapy windows.  Advanced imaging 
is also important in pediatric ischemic stroke which requires a slightly different workflow 
and treatment approach.  Here, we will discuss key imaging findings in acute ischemic 
stroke, as well as the present and future of neuroimaging in light of recent and ongoing 
clinical trials.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction: 
The critical component of acute ischemic stroke (AIS) management is early 
revascularization of at-risk but potentially salvageable brain tissue, which can be viable 
for a period of time due to collateral perfusion1. The role of imaging in acute ischemic 
stroke is therefore to identify affected brain parenchyma and to delineate any areas of 
potentially salvageable tissue with the goal of early intervention and reperfusion. 
With the success of recent endovascular therapy trials, there has been a paradigm shift 
from use of Intravenous tissue-type plasminogen activator (IV-tPA) alone to the addition 
of early endovascular therapy in appropriately selected patients. Intravenous tPA alone 
is generally better for reperfusion of small distal vessel occlusions than large proximal 
occlusions2,3 Rapid multimodal imaging is therefore critically important to identify 
patients who may benefit most from endovascular therapy. The use of various rapid 
imaging techniques has been an integral component of recent major stroke trials and 
are detailed in this review.4,5,6,7  With the use of advanced CT imaging tools, the time 
taken from stroke onset to first reperfusion has not substantially increased in some 
trials.8  However, there are a few additional recent trials which have used MRI and 
perfusion imaging to identify patients eligible for endovascular therapy or thrombectomy 
up to 6 to 24 hours after stroke symptom onset.9,10 Another important area of research is 
the use of MRI to identify eligible candidates for thrombolysis when symptom onset is 
unknown.11 
Here, we discuss the parenchymal imaging findings of AIS with a focus on multimodal 
CT and MRI including angiographic and perfusion imaging.  We will also describe how 
multimodal imaging can be incorporated into the existing stroke imaging workflow and 
briefly discuss imaging in pediatric ischemic stroke. 
CT Parenchymal Findings: 
Non-contrast enhanced CT (NCCT) remains a first-line imaging technique in the 
evaluation of suspected acute ischemic stroke.  It is used to rapidly assess for any 
mimics of acute stroke and to identify evidence of an intracerebral hemorrhage which 
would contraindicate intravenous tissue plasminogen activator (IV tPA) therapy.12,13   
Parenchymal findings of AIS can be detected very early with NCCT, with abnormalities 
found in up to 75% of patients with MCA stroke within 3 hours.14 When AIS occurs there 
is an increase in intracellular water, or cytotoxic edema, in the affected parenchyma.  
This manifests on NCCT as decreased attenuation of tissue, loss of gray-white matter 
differentiation, and focal swelling which can lead to effacement of the sulci or mass 
effect (Fig. 1A, 1B). In the setting of MCA territory infarct, the loss of tissue attenuation 
can be detected early in the basal ganglia, particularly in the lentiform nucleus.  Another 
early sign of MCA territory infarct is loss of gray-white differentiation at the insular cortex 
which is known as the “insular ribbon sign.” These findings can be subtle in the early 
time windows and it is important to use narrow window settings to detect them.13 NCCT 
can also allow direct visualization of a hyperdense thrombus in an occluded artery (Fig. 
1C), known as the “dense vessel sign.” In the setting of low hematocrit or the presence 
of imaging artifact, this sign may not be detected and thus it is not very sensitive.  It is, 
however, very specific when mimics such as arterial calcifications are excluded.13,14   
An objective way to evaluate the extent of ischemic changes and estimate patient 
prognosis is the widely used Alberta Stroke Program Early CT Scale system 
(ASPECTS), which was initially proposed in 2000.  The ASPECTS scale is a negative 
ordinal scale which assigns an equally weighted score of 1 to 10 to different MCA 
territory regions of interest on NCCT imaging.  These regions include the caudate 
nucleus (C), insular ribbon (I), internal capsule (IC), lentiform nucleus ( L), and 6 cortical 
MCA territory regions divided into superior and inferior anterior, middle, and posterior 
regions (M1-M6).  These regions are assessed for early ischemic changes (EIC), which 
are defined as hypoattenuation or loss of gray-white differentiation.  Isolated cerebral 
swelling without associated hypoattenuation is not considered an EIC because it may 
be seen with potentially viable parenchyma.15  A final ASPECTS score of 7 or less is 
associated with poorer prognosis due to a larger affected area.15 Some of the recent 
positive endovascular trials used ASPECTS as a selection criteria.  A recent meta-
analysis from the five thrombectomy trials in 2015 found a clear benefit of 
thrombectomy in patients with ASPECTS >5.16 One such trial is the Thrombectomy 
Within 8 Hours after Symptom Onset in Ischemic Stroke (REVASCAT) which used a CT 
ASPECTS of >7 as a treatment cutoff.17 ASPECTS can also be evaluated on CT 
Angiography source images (CTA-SI) which are often obtained immediately following 
NCCT.  CTA-SI can detect cerebral blood volume or flow abnormalities reflecting 
decreased perfusion which may not be able to be seen on NCCT.  It has been 
suggested that CTA-SI ASPECTS is a better predictor for clinical outcomes and when 
compared to NCCT ASPECTS (Fig. 2).18 However, CTA-SI defined hypodensity is 
dependent on the CTA acquisition protocol and type of CT scanner. It is important to 
note that ASPECTS has limitations including moderately low intra-rater agreement. 
Furthermore, use of a single threshold to identify patients with poor outcome might lead 
to unjustified exclusion of patients from clinical trials or even treatment.  There is active 
ongoing research to further evaluate the clinical use of ASPECTS and to apply it to 
different imaging modalities.15,19,20 
MRI Parenchymal Findings: 
MRI is more sensitive than NCCT in detecting AIS and hence an alternative to NCCT for 
acute stroke evaluation, provided it does not delay potential IV tPA or endovascular 
therapy.12,13 MRI can detect intracranial hemorrhage with the same sensitivity as NCCT 
and can also provide information on the age of the bleed.12  In the hyperacute to acute 
phase, blood is typically T1 isointense and T2/FLAIR iso- to hyperintense.   As 
intracellular methemoglobin content increases after the first 48 hours, T1 signal 
gradually increases.21  Chronic hemorrhages lose their T1 and T2 signal but are readily 
detectable with susceptibility weighted imaging as areas of signal dropout or blooming.  
Similar to the “dense vessel sign” on CT (Fig 3A), gradient echo (GRE) or susceptibilitity 
weighted images (SWI) on MRI can also help in visualizing the acute thrombus as an 
area of susceptibility or “blooming”(Fig. 3B). The presence of multiple cerebral 
microhemorrhages can sometimes pose a problem in clinical decision making.  While 
patients with a few (<5) microhemorrhages may not be at increased risk, recent 
literature suggests that patients with multiple (>10) microhemorrhages are at increased 
risk for symptomatic ICH after thrombolytic therapy.  Official recommendations for this 
scenario are still being established.12,21,22 
Cytotoxic edema of acute infarct leads to decreased free diffusion of water, resulting in 
a decreased apparent diffusion coefficient (ADC) and increased signal on diffusion 
weighted imaging (DWI)(Fig. 3C, 3D, 4).  DWI can detect an acute ischemic event 
within minutes and is an essential MRI sequence in acute stroke imaging.14  The area of 
diffusion restriction represents the “core” or irreversible injury which can expand over 24 
hours if there is no reperfusion of potentially salvageable brain tissue.  After the acute 
phase, vasogenic edema and cellular breakdown lead to an increase in extracellular 
water and a gradual increase in ADC signal over 9-11 days.14 
Because diffusion restriction occurs very early following acute ischemic stroke, its 
presence can be used to estimate stroke timing.  For example, a positive DWI and 
negative FLAIR, or DWI-FLAIR mismatch, can be used to determine that a stroke is 
within 4.5 hours of onset with an 83-87% positive predictive value.23  This is because 
the tissue damage which causes FLAIR abnormality has not yet occurred within that 
window.  As shown in the Efficacy and Safety of MRI-based Thrombolysis in Wake-up 
Stroke (WAKE-UP) trial, the concept of DWI-FLAIR mismatch can be used to identify 
potential thrombolysis candidates when there is unknown symptom onset or a “wake-
up” stroke.11 
Vascular imaging and Collateral Assessment:  
Non-invasive vascular imaging is now commonly used in the workup of AIS, particularly 
when endovascular therapy is contemplated.  The recently positive endovascular trials 
used CTA as an imaging selection tool to identify patients with proximal anterior 
circulation occlusions.4,5,6,7 The major goals of CTA are to identify proximal vessel 
occlusion, assess collateral circulation, and to aid in planning for endovascular 
treatment.24  
 
Identification of large vessel occlusion (Fig. 5): Although a large percentage of patients 
with AIS (19 – 39%) have no identifiable thrombus, those with thrombus have more 
severe strokes at baseline and are more likely to demonstrate large or proximal vessel 
occlusion, including ICA and MCA-M1 occlusions.8,25  In general, patients with longer, 
more proximal thrombi are more likely to benefit from endovascular thrombectomy and 
less likely to recanalize with IV tPA alone.25  The “clot burden score” was developed to 
address the difficulty of measuring precise thrombus length and to create a model for 
predicting outcome based on intracranial vessel involvement.  The “clot burden score” 
starts with a score of 10 and subtracts points for involvement of certain vessels:  1 for 
infraclinoidal ICA, 2 for supraclinoidal ICA, 2 for proximal M1, 2 for distal M1, 1 for M2, 
and 1 for ACA (Fig. 5).  A score of less than 10 was shown to be associated with 
reduced odds of long independent functional outcome with an odds ratio (OR) of as low 
as 0.09 for scores less than 5.26 
 
CTA can also help in assessing collateral circulation, which can affect the rate of infarct 
growth. Patients with good collaterals generally can prevent irreversible infarction in 
susceptible brain parenchyma.8 Collateral grading can be used for therapeutic decision 
making even using a simple grading scale.  In a post hoc analysis of the Randomized 
Trial of Intraarterial Treatment for Acute Ischemic Stoke (MR CLEAN) trial, collateral 
circulation was graded using four categories: grade 0 (no collaterals), grade 1 (<50% 
filling in the occluded territory), grade 2(50 to 100% filling in the occluded territory) and 
grade 3 (100% filling).  They demonstrated that patients with good collaterals (grade 3) 
had better response to intra-arterial therapy than patients with poor collaterals (Fig. 6) 
using the primary outcome of 90 day modified Rankin Scale scores.4,27 Accurate 
collateral grading has been further enhanced with multiphase CTA (Fig. 7), which is 
performed by scanning from the aortic arch to the vertex in peak arterial phase followed 
by two sequential scans from the skull base to vertex in peak and late venous phases.  
This allows for temporal resolution which traditional single-phase CTA does not 
provide.8    
Finally, CTA can be useful in planning for endovascular therapy including evaluation of  
caliber and tortuosity of the intracranial and extracranial vessels, visualizing the 
ipsilateral carotid bifurcation, and to identify any variant anatomy.  Information on 
additional pathology including stenosis, dissection, or aneurysm can all aid in device 
selection and access planning for intervention or alternative management.8   
Perfusion Imaging: 
The main goal of perfusion imaging is to discriminate between “penumbra” and the 
ischemic “core.” The penumbra is defined as hypoperfused but potentially salvagable 
brain tissue. This is in contrast to the core which represents tissue that is irreversibly 
damaged.  Because the penumbra can persist and the core can continue to enlarge 
beyond 12 hours from stroke onset, this discrimination can aid in clinical decision 
making even after the traditional acute endovascular treatment window of 6 hours.28 
Both CT perfusion (CTP) and MRI perfusion weighted imaging (PWI) are accomplished 
by injecting a tracked bolus of IV contrast and serially imaging a volume of brain 
parenchyma during the injection.29  An advantage of CTP is that whole brain perfusion 
images can be obtained along with CTA using a single contrast bolus immediately 
following NCCT.30 Post-processing software is then used to calculate a variety of 
parameters based on the scan data and to generate perfusion maps.  In the setting of 
CTP, the most commonly employed processing algorithm involves a deconvolution 
technique which takes into account variations in arterial inflow, venous outflow, and 
collateral circulation.29  The calculated maps for perfusion imaging include cerebral 
blood volume, cerebral blood flow, mean transit time (MTT) and time-to-max or time-to-
peak contrast concentration (Tmax)(Fig. 8).13,28 
In general, critically hypoperfused tissue has a Tmax > 6 seconds and has been 
validated in multiple studies.28,31  The mismatch between the total area of critically 
hypoperfused tissue and the ischemic core is used to estimate the penumbra (Fig 8).  
With MRI, the biggest advantage is that the ischemic core is reliably represented by the 
acutely infarcted area on DWI imaging.  In contrast, core is indirectly estimated in CTP 
either using thresholds of CBV < 2 – 2.2 g/100 ml or more recently using decrease in 
CBF of 30-50% compared to normal tissue.29  This penumbra/core mismatch concept 
has been evaluated as a selection criteria in several clinical trials. In the Diffusion 
Weighted Imaging Evaluation for Understanding Stroke Evolution Study-2 (DEFUSE 2) 
trial, a group of patients who underwent endovascular reperfusion within 12 hours of 
stroke onset were evaluated for “Target Mismatch”; criteria included a ratio of critically 
hypoperfused tissue to ischemic core ≥ 1.8, an ischemic core < 70 ml, and less than 
100 ml of total tissue with Tmax > 10 seconds.  They demonstrated that patients who 
met Target Mismatch criteria had more favorable clinical outcomes and less infarct 
growth following endovascular reperfusion when compared to patients who did not meet 
the criteria.31  The Endovascular Therapy for Ischemic Stroke With Perfusion-Imaging 
Selection (EXTEND IA) trial which used CTP for all patients required evidence of 
salvageable tissue and excluded patients with a large ischemic core >70 mL.6  The 
Stent-Retriever Thrombectomy after Intravenous tPA vs. t-PA Alone in Stroke (SWIFT 
PRIME) trial excluded patients with a core  >50 mL or patients with >100 ml brain tissue 
with t-max > 10 seconds7  Early results from the recent Clinical Mismatch in the Triage 
of Wake-up and Late Presenting Strokes Undergoing Neurointervention with Trevo 
(DAWN) trial, which also used perfusion as a selection tool,  demonstrated that 
endovascular treatment up to 24 hours of stroke onset significantly decreased 
poststroke disability and improved functional independence at 90 days when compared 
to medical management alone.9,10 
Some of the disadvantages of CTP is lack of whole brain coverage and lack of 
standardization. However, newer scanners are capable of large areas of coverage. 
Using fully automated software for post-processing of CTP is ideal and allows efficiency, 
standardization of processing methodology and perfusion map appearance, and can 
also be compared easily in multicenter trials. Trials such as EXTEND-IA, SWIFT PRIME 
and DAWN have demonstrated the feasibility of modern CTP with standardized 
automated processing and their use in triaging patients with acute ischemic stroke.6,7,9 
 
 
AHA Recommendations for Imaging in Acute Stroke: 
According to the American Heart Association guidelines, emergency imaging of the 
brain, most commonly NCCT, is recommended before any specific treatment for acute 
stroke is initiated (Class I; Level of Evidence A).  If endovascular therapy is 
contemplated, a noninvasive intracranial vascular study is strongly recommended but 
should not delay intravenous r-tPA if indicated. (Class I; Level of Evidence A). This is a 
new recommendation in the 2015 update based on the multiple endovascular trials.32   
Benefits of perfusion studies remain unknown (Class IIb; Level of Evidence 
C).31  Further randomized controlled trials may be helpful to determine whether 
advanced imaging paradigms with perfusion or angiographic imaging are beneficial for 
selecting patients within 6 hours of symptom onset and with an ASPECTS <6. Also, 
according to AHA guidelines, further randomized, controlled trials should be done to 
determine whether advanced imaging paradigms with CT or MR perfusion are beneficial 
for selecting patients for acute reperfusion therapy who are beyond 6 hours from 
symptom onset.31 However, the rapidly changing landscape of acute stroke treatment 
including the recent DAWN results may prompt additional AHA updates on imaging 
requirements of patient subgroup beyond 6 hours.9 
Optimizing Imaging Workflow: 
Time is of essense in management of an acute stroke patient as “Time is Brain”. 
Approximately 1.9 million neurons are destroyed every minute in the territory of 
occluded artery.33  Early reperfusion is a critical factor for good outcomes. As imaging is 
an integral part of the workup, all imaging needs to be performed and interpreted in a 
timely, efficient manner. Thus, important aspects of the stroke workflow center around 
the imaging department such as patient triaging, image acquisition, image interpretation 
and decision making.34 Although the imaging paradigms may be slightly different in 
different institutions, it is important to remember that any imaging including CTA or CTP 
should not introduce delays in treatment. Parallel processes in the stroke workflow 
should be encouraged.  For example, IV tPA can be started in the scanner as a 
CTA/CTP is being performed. Delaying a CTA for availability of renal function tests is 
suboptimal. Studies have shown that there is no significant difference in the incidence of 
acute renal injury between contrast enhanced and non-enhanced CT scans, irrespective 
of the baseline renal function.35  
Time metrics are also important for interpretation of the imaging studies. The“Get with 
Guidelines”recommends that non contrast head CT in suspected acute stroke should be 
obtained within 25 min of admission to the emergency department and that these scans 
be interpreted within 20 min of being obtained. Ideally, patient should be transferred 
from “Door-to- Scanner”, by-passing the Emergency department and saving time. 
Multidisciplinary teamwork and standardized institutional protocols contribute to 
improved times to treat and in turn improved functional outcome.36 It is critical that the 
radiologist is an integral part of this team to optimize imaging work up of AIS patients.  
Pediatric Stroke: 
There is increasing recognition of the occurrence of ischemic stroke in children.  
Currently reported annual incidence of pediatric arterial ischemic stroke in North 
America is between 2-3 per 100,000 children, which is much lower than the incidence in 
adults.37 However, this incidence of pediatric stroke is likely underreported because of 
lack of accurate diagnosis.38 Ischemic stroke in children may be due to arterial or 
venous ischemia, and can include neonatal/perinatal stroke, childhood ischemic stroke 
and stroke in the adolescent and young adult.  
Childhood AIS has distinct risk factors compared to adult stroke.  Unlike adults, 
atherosclerotic disease is rare in children. In a large series of children with arterial 
ischemic stroke (AIS) studied by the international pediatric stroke study (IPSS), 
approximately 90% had at least one risk factor identified, such as vasculitis (Fig. 9).39,40 
Childhood AIS can lead to permanent neurological deficits in approximately three 
fourths of the cases, and lead to death in 10% of cases.41,42. Approximately 20% of 
children with arterial ischemic strokes can suffer recurrences within five years.41 
In many children with stroke, imaging, and accurate diagnosis may be delayed due to 
lack of clinical suspicion.38  Presenting symptoms of childhood stroke can be 
misdiagnosed as seizure, altered mental status, lethargy or headache due to lack of 
awareness by families and medical providers.39 Additionally, there are many stroke 
mimics in the pediatric population including metabolic encephalopathy with stroke-like 
symptoms (MELAS), posterior reversible encephalopathy syndrome (PRES), or other 
toxic and metabolic abnormalities.  
Many factors determine the imaging study that is eventually performed when there is a 
suspicion of stroke in children. The age of the patient is important as children younger 
than four years of age are generally unable to hold still for an MRI. As some imaging 
centers may not have MRI technologists in-house at all times, after hours presentation 
could be another factor to consider. Nevertheless, early imaging is key. A non-contrast 
head CT followed by contrast enhanced CTA of the head and neck would be the best 
initial work up if an emergent MRI cannot be performed due to availability or 
contraindication.43  As always, the risk of ionizing radiation should be considered in 
children and should be weighed against the benefits of emergent CT imaging.44,45,46 
Non-contrast MR perfusion methods using arterial spin labelling ASL have shown 
comparable sensitive to gadolinium-based perfusion in identifying the perfusion defect 
in childhood AIS (Fig. 9C). Recently, gadolinium deposition in the brain have been 
shown after cumulative doses of linear gadolinium contrast agents.47, Thus, non-
contrast MR perfusion methods such as arterial spin labelled (ASL) are used more 
frequently in the pediatric population.48 Susceptibility weighted imaging (SWI) is also a 
promising tool in childhood AIS, with mismatch of diffusion and hypointense venous 
SWI signal predicting stroke progression.49 SWI reflects blood oxygenation levels, and 
SWI values in the veins can provide an alternative assessment of  degree of brain 
perfusion and the perfusion-diffusion mismatch. 
Vessel wall imaging (Fig. 9E) is a relatively new MR technique that can give detailed 
information regarding vessel wall thickening, luminal narrowing and enhancement; 
assessing among other things the presence of arterial inflammation. It holds promise in 
the decision making process of Childhood AIS, particularly when an arteriopathy such 
as vasculitis, is suspected.50 Findings that would suggest arteriopathy include, 
dissection, arterial banding, luminal narrowing, wall irregularity, beading, ectasia, 
aneurysm or pseudoaneurysm.51  
Childhood stroke is usually treated conservatively, with no established benefit of 
endovascular therapy. 
Future Directions and Ongoing Trials: 
Future directions in acute ischemic stroke imaging include continuing to improve 
outcomes by early recognition, streamlined workflow, and appropriate triage. Areas of 
inquiry will be in the development and application of rapid, reliable imaging techniques 
and standardization of protocols with a focus on image quality and quantification.  
Additionally, there are continued efforts to expand treatment windows. 
Some of the trials spearheading these advances include the recently positive DAWN 
trial9,10  Additional ongoing studies include a Study of Intravenous Thrombolysis With 
Alteplase in MRI-Selected Patients (MR WITNESS), where MR findings of acute stroke 
are used to initiate intravenous tPA within 4.5 hours of stroke onset (NCT01282242).  
The Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-3 
(DEFUSE 3) trial which was focusing on anterior circulation stroke presenting 6-16 
hours after onset was recently halted after interim analysis.52 Eligibility was  based on 
presence of proximal occlusion and target mismatch profile on MR or CT perfusion 
calculated and the results are expected in the near future (NCT02586415).  Perfusion 
Imaging Selection of Ischemic Stroke Patients for Endovascular Therapy (POSITIVE) 
stroke trial is an ongoing trial assessing the benefit of endovascular treatment versus 
medical management in late presenting strokes 6-12 hours after onset (NCT01852201).  
Other stroke trials are testing the use of intravenous tPA in late presenting strokes (4.5 
to 9 hours) such as the European Cooperative Acute Stroke Study (ECASS)-IV.8  The 
key points from the major trials we have discussed are outlined in Table 1.   
Trial MR CLEAN EXTEND IA SWIFT PRIME WAKE UP REVASCAT ESCAPE DEFUSE 3 DAWN 
Primary 
Imaging 
Modalities 
NCCT + CTA, 
MRA, or DSA 
NCCT, CTP 
NCCT, CTP MRI NCCT, MRI NCCT, CTA 
(multiphasic) 
CTA, CTP, MRI, 
MRA 
NCCT, MRI 
MRA, CTP, CTA 
Treatment 
Window 
<6 hours <4.5 hours < 6 hours <4.5 hrs. after 
symptom 
recognition 
<8 hours <12 hours 6-16 hours 6 – 24 hours 
Main 
Imaging 
Criteria 
Proximal 
occlusion 
Proximal 
occlusion,  Core 
< 70 ml 
Proximal 
occlusion, Core 
< 50 ml 
DWI – FLAIR 
Mismatch 
Proximal 
occlusion, CT 
ASPECTS ≥7 or 
DWI ASPECTS ≥ 
6 
ASPECTS >6, 
moderate to 
good 
collaterals, 
proximal 
occlusion 
Target 
Mismatch 
Profile (core < 
70 ml, 
mismatch ratio 
> 1.8 and 
mismatch vol. 
> 15 ml) 
Clinical 
Imaging 
Mismatch 
(core < 21 ml, 
31 ml, or 51 ml 
depending on 
age and NIHSS) 
Intervention  Intra-arterial 
Therapy vs 
Standard Care 
Thrombectomy 
vs Standard 
Care 
Thrombectomy 
vs Standard 
Care 
IV tPA vs None Thrombectomy 
vs Standard 
Care 
Thrombectomy 
vs Standard 
Care 
Thrombectomy  
vs. Standard 
Care 
Thrombectomy 
vs Standard 
care 
Primary 
Clinical 
Outcome 
90 Day modified 
Rankin Score 
24-Hour 
reperfusion 
90 day 
modified 
Rankin Score 
90 day 
modified 
Rankin Score 
90 day 
modified 
Rankin Score 
90 day 
modified 
Rankin Score 
90 day 
modified 
Rankin Score 
90 day 
modified 
Rankin Score 
Comment Benefit of intra 
arterial therapy.  
Better outcomes 
with good 
collaterals on 
CTA 
CTP for patient 
selection.  
Benefit of early 
endovascular 
treatment. 
CTP for patient 
selection.  
Benefit of early 
endovascular 
treatment. 
Can use MRI to 
determine 
stroke age < 
4.5 hours 
Extended 
endovascular 
treatment 
window to 8 
hours 
Extended  
endovascular 
treatment 
window to 12 
hours 
Extended 
treatment 
window to 6-
24 hours with 
appropriate 
mismatch 
Extended 
treatment 
window  to 24 
hours with 
appropriate 
mismatch 
Table 1. 
 
 
Conclusion: 
Rapid multimodal imaging is essential as soon as acute ischemic stroke is suspected.  
Initial NCCT or MRI is critical to identify contraindications to IV tPA and evaluate the 
extent of the infarct.  Objective scoring systems such as ASPECTS and ASPECTS-
based thresholds are commonly used for treatment triage. Vessel based imaging is 
additionally performed to identify patients with large proximal vessel occlusions who are 
candidates for endovascular therapy or treatment in extended time windows. Using 
perfusion imaging, new endovascular stroke trials such as DAWN trial have extended 
the stroke treatment time window up to 24 hours after stroke onset. Because the 
imaging criteria for treatment candidates continue to evolve, it is critical for radiology 
departments to understand current recommendations and guidelines in order to make 
appropriate adjustments to their workflow.  This also requires collaboration and 
coordination with other providers including the prehospital EMS, emergency 
department, stroke neurologists, and neuro-interventionalists.  The subgroup of 
pediatric stroke is rare, nevertheless important, would need high index of suspicion as 
the presentation and etiology is different from adults.  Many of the imaging based 
selection criteria for extending treatment windows is soon becoming standard of care 
and may be reflected in future national guidelines. These exciting changes will pave the 
way for future stroke research and management to improve stroke outcomes. 
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Figure Legends: 
Table 1. Key points from recent and ongoing stroke trials.4,5,6,7,9,11,17,52 “Standard 
Care” is defined as administration of IV tPA within 4.5 hours of stroke onset if there are 
no contraindications.  In the treatment arms, IV tPA was not withheld if indicated.  
“Proximal Occlusion” is defined as a large anterior circulation vessel occlusion.Figure 1.  
CT Parenchymal and Vascular Findings in Acute Stroke. 45 year old male with right 
sided weakness, 5 hours since last known prior.  Axial non-contrast CT images (A, B, C) 
demonstrate hypoattenuation and loss of gray-white differentiation in the left MCA 
distribution with involvement of the internal capsule, lentiform nuclei, and insular cortex 
(arrows on A, B).  There is a left “hyperdense vessel” sign (bold arrow on C) indicative of 
left M1 thrombus. Axial CT Angiography image (D) confirmed the occlusive thrombus 
(arrow). 
 
Figure 2.  Non-contrast CT (NCCT) and CT-Angiography Source Images (CTA-SI) 
ASPECTS. Patient presented with right-sided weakness and concern for acute stroke.  
Initial NCCT (A, B) demonstrates no signs of ischemia, ASPECTS score = 0.  CTA 
Source Images (CTA-SI) obtained 11 minutes later (C, D) demonstrate a large left MCA 
territory stroke with ASPECTS score = 2, sparing only the internal capsule and head of 
the caudate.  
 
Figure 3.  MRI Findings in acute ischemic stroke.  84 year-old lady who presented 
with dysarthria. Initial NCCT demonstrates a tiny left “MCA dot sign” (arrow) with 
hypoattenuation in the adjacent insular cortex( A).  Subsequent MRI (B) shows a 
“blooming thrombus” on susceptibility weighted imaging (arrow on B).  Corresponding 
DWI (C) and ADC map (D) confirm area of restricted diffusion consistent with an acute 
infarct in this territory. 
 
 
Figure 4: Acute Infarct on Diffusion-Weigthed Imaging (DWI). Patient with left sided 
weakness.  A large area of diffusion restriction on DWI (A) and ADC (B) images is 
consistent with acute right MCA territory infarct with mild mass effect on the right lateral 
ventricle. 
 
Figure 5: Vascular Imaging and Endovascular Therapy on Acute Ischemic Stroke.  
Axial CT angiography (A) showing an occluded right MCA (arrow) with moderate 
collateral circulation.  Right MCA thrombus on 3D reconstruction images (B) (bold 
arrow).  Pre- (C) and post- (D) mechanical thrombectomy digital subtraction 
angiography images show successful reperfusion of the right MCA (arrows on C and D).   
 
Figure 6:  Moderate Collaterals on CT-Angiography.  Multiphasic CTA in a patient 
with mild right MCA stenosis.  Images were obtained in arterial (A), mid venous (B), and 
delayed venous (C) phases and demonstrate sluggish, delayed filling of right sided 
collateral vessels (arrows).   
 
Figure 7: Poor Collaterals on CT-Angiography.  A patient with a large left MCA 
territory infarct demonstrates absent collaterals (arrows) on frontal CTA (A).  The patient 
was ineligible for endovascular therapy and subsequently required decompressive 
craniotomy (B). 
 
Figure 8: CT Perfusion in Acute Ischemia.  Post-processed CT perfusion images 
from a patient with an acute right MCA territory infarct.  The images in (A) show NCCT 
and perfusion maps, from left to right, of cerebral blood volume (CBV), cerebral blood 
flow (CBF), mean transit time (MTT) and time to maximum (Tmax).  The perfusion maps 
are color coded with darker areas on the CBV and CBF maps representing decreased 
blood volume and perfusion.  The MTT and Tmax maps have color coded scales.  For 
example, blue areas on the Tmax map represent areas of Tmax between 4 and 6 
seconds while red areas represent Tmax > 10 seconds.  The core (B) was estimated 
using threshold of CBF of 0.3 (arrows on B).  The penumbral volumes (C) were 
calculated using Tmax >6 sec. (arrows on C). 
 
Figure 9: Probable Vasculitis on Pediatric Stroke. 4 year old girl presenting with 
acute stroke. FLAIR (A) image with hyperintensity in the left basal ganglia (arrow on A).  
ADC maps (B) demonstrate true diffusion restriction consistent with acute infarct. 
pCASL flow images (C) demonstrate decreased flow in the left basal ganglia (arrow). 
MIP images from MR angiogram (D) demonstrates narrowing of the distal left internal 
carotid artery and proximal MCA and ACA (bold arrow). T1 post contrast imaging of the 
vessel wall (E) demonstrates diffuse asymmetric enhancement of the left petrous 
internal carotid artery (arrow on E) suggesting vasculitis.  
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